Common stock only | |
S&P 500 only | |
Director Only | |
10% Owner Only |
Trans Codes
Select...
Amount
-
Trade GOSS Insider Trades:
all
Unusual
Whales
Unusual Whales
Unusual Whales
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-03-04
2025-03-06
ARANDA RICHARD
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
572K
$0.00
1
$263.67M
2025-03-04
2025-03-06
HASNAIN FAHEEM
President & CEO
A - Grant
Stock Option (Right to Buy)
1.54M
$0.00
1
$263.67M
2025-03-04
2025-03-06
PETERSON CARYN
EVP, Regulatory Affairs
A - Grant
Stock Option (Right to Buy)
440K
$0.00
1
$263.67M
2025-03-04
2025-03-06
CHRISTIAN WAAGE
EVP, Tech Ops and Admin
A - Grant
Stock Option (Right to Buy)
440K
$0.00
1
$263.67M
2025-03-04
2025-03-06
SMITH ROBERT PAUL JR
Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
572K
$0.00
1
$263.67M
2024-06-24
2024-06-25
ARANDA RICHARD
Chief Medical Officer
S - Sale
Common Stock
-1,908
$1.00
-1,908
1
$263.67M
2024-06-17
2024-06-20
SMITH ROBERT PAUL JR
Chief Commercial Officer
P - Purchase
Common Stock
25,000
$1.00
25,000
1
$263.67M
2024-06-06
2024-06-06
COX RUSSELL
A - Grant
Non-qualified stock option (Right to Buy)
115K
$0.00
1
$263.67M
2024-06-06
2024-06-06
DANIEL THOMAS
A - Grant
Non-qualified stock option (Right to Buy)
115K
$0.00
1
$263.67M
2024-06-06
2024-06-06
MILLIGAN SANDRA
A - Grant
Non-qualified stock option (Right to Buy)
115K
$0.00
1
$263.67M
2024-06-06
2024-06-06
QUISEL JOHN
A - Grant
Non-qualified stock option (Right to Buy)
115K
$0.00
1
$263.67M
2024-03-27
2024-03-28
CHRISTIAN WAAGE
EVP, Tech Ops and Admin
S - Sale
Common Stock
-6,430
$1.00
-6,430
1
$263.67M
2024-03-27
2024-03-28
HASNAIN FAHEEM
President & CEO
S - Sale
Common Stock
-23,172
$1.00
-23,172
1
$263.67M
2024-03-18
2024-03-19
ARANDA RICHARD
Chief Medical Officer
S - Sale
Common Stock
-4,018
$1.00
-4,018
1
$263.67M
2024-03-18
2024-03-19
PETERSON CARYN
EVP, Regulatory Affairs
S - Sale
Common Stock
-4,018
$1.00
-4,018
1
$263.67M
2024-01-02
2024-01-04
ARANDA RICHARD
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
488K
$0.00
1
$263.67M
2024-01-02
2024-01-04
CHRISTIAN WAAGE
EVP, Tech Ops and Admin
A - Grant
Stock Option (Right to Buy)
375K
$0.00
1
$263.67M
2024-01-02
2024-01-04
HASNAIN FAHEEM
President & CEO
A - Grant
Stock Option (Right to Buy)
1.31M
$0.00
1
$263.67M
2024-01-02
2024-01-04
PETERSON CARYN
EVP, Regulatory Affairs
A - Grant
Stock Option (Right to Buy)
375K
$0.00
1
$263.67M
2023-12-04
2023-12-05
SMITH ROBERT PAUL JR
Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
1.50M
$0.00
1
$263.67M
2023-11-20
2023-11-22
ARANDA RICHARD
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
163K
$0.00
1
$263.67M
2023-11-20
2023-11-22
CHRISTIAN WAAGE
EVP, Tech Ops and Admin
A - Grant
Stock Option (Right to Buy)
125K
$0.00
1
$263.67M
2023-11-20
2023-11-22
HASNAIN FAHEEM
President & CEO
A - Grant
Stock Option (Right to Buy)
438K
$0.00
1
$263.67M
2023-11-20
2023-11-22
PETERSON CARYN
EVP, Regulatory Affairs
A - Grant
Stock Option (Right to Buy)
125K
$0.00
1
$263.67M
2023-07-24
2023-07-26
HASNAIN FAHEEM
President & CEO
A - Grant
Common Stock Purchase Warrants
135K
$0.00
1
$263.67M
2023-07-24
2023-07-26
CHRISTIAN WAAGE
EVP, Tech Ops and Admin
A - Grant
Common Stock Purchase Warrants
3,376
$0.00
1
$263.67M
2023-07-24
2023-07-26
CHRISTIAN WAAGE
EVP, Tech Ops and Admin
A - Grant
Common Stock
13,504
$2.00
27,008
1
$263.67M
2023-06-22
2023-06-26
ARANDA RICHARD
Chief Medical Officer
S - Sale
Common Stock
-1,814
$1.00
-1,814
1
$263.67M
2023-05-05
2023-05-09
CHRISTIAN WAAGE
EVP, Tech Ops and Admin
A - Grant
Stock Option (Right to Buy)
304K
4
$263.67M
2023-05-05
2023-05-09
PETERSON CARYN
EVP, Regulatory Affairs
D - Sale to Issuer
Stock Option (Right to Buy)
-346K
6
$263.67M
2023-05-05
2023-05-09
ARANDA RICHARD
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
249K
6
$263.67M
2023-05-05
2023-05-09
HASNAIN FAHEEM
President & CEO
A - Grant
Stock Option (Right to Buy)
750K
$0.00
1
$263.67M
2023-05-05
2023-05-09
PETERSON CARYN
EVP, Regulatory Affairs
A - Grant
Stock Option (Right to Buy)
231K
6
$263.67M
2023-05-05
2023-05-09
ARANDA RICHARD
Chief Medical Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-373K
6
$263.67M
2023-05-05
2023-05-09
CHRISTIAN WAAGE
EVP, Tech Ops and Admin
D - Sale to Issuer
Stock Option (Right to Buy)
-457K
4
$263.67M
2023-05-05
2023-05-09
GIRAUDO BRYAN
COO/CFO
D - Sale to Issuer
Stock Option (Right to Buy)
-722K
5
$263.67M
2023-03-20
2023-03-22
CHRISTIAN WAAGE
EVP, Tech Ops and Admin
A - Grant
Stock Option (Right to Buy)
158K
$0.00
1
$263.67M
2023-03-20
2023-03-22
ARANDA RICHARD
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
158K
$0.00
1
$263.67M
2023-03-20
2023-03-22
CARTER LAURA
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
158K
$0.00
1
$263.67M
2023-03-20
2023-03-22
HASNAIN FAHEEM
President & CEO
A - Grant
Stock Option (Right to Buy)
545K
$0.00
1
$263.67M
2023-03-20
2023-03-22
PETERSON CARYN
EVP, Regulatory Affairs
A - Grant
Stock Option (Right to Buy)
158K
$0.00
1
$263.67M
2023-03-20
2023-03-22
CHRISTIAN WAAGE
EVP, Tech Ops and Admin
P - Purchase
Common Stock
18,500
$1.00
18,500
1
$263.67M
2023-03-16
2023-03-20
ARANDA RICHARD
Chief Medical Officer
S - Sale
Common Stock
-7,563
$1.00
-7,563
1
$263.67M
2023-03-16
2023-03-20
CARTER LAURA
Chief Scientific Officer
S - Sale
Common Stock
-6,029
$1.00
-6,029
1
$263.67M
2023-03-16
2023-03-20
PETERSON CARYN
EVP, Regulatory Affairs
S - Sale
Common Stock
-7,564
$1.00
-7,564
1
$263.67M
2022-12-07
2022-12-09
ARANDA RICHARD
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
158K
$0.00
1
$263.67M
2022-12-07
2022-12-09
CARTER LAURA
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
158K
$0.00
1
$263.67M
2022-12-07
2022-12-09
CHRISTIAN WAAGE
EVP, Tech Ops and Admin
A - Grant
Stock Option (Right to Buy)
158K
$0.00
1
$263.67M
2022-12-07
2022-12-09
HASNAIN FAHEEM
President & CEO
A - Grant
Stock Option (Right to Buy)
545K
$0.00
1
$263.67M
2022-12-07
2022-12-09
PETERSON CARYN
EVP, Regulatory Affairs
A - Grant
Stock Option (Right to Buy)
158K
$0.00
1
$263.67M
2022-10-24
2022-10-27
CARTER LAURA
Chief Scientific Officer
S - Sale
Common Stock
-4,876
$12.00
-58,512
1
$263.67M
2022-10-24
2022-10-25
PETERSON CARYN
EVP, Regulatory Affairs
S - Sale
Common Stock
-4,757
$12.00
-57,084
1
$263.67M
2022-10-24
2022-10-25
ARANDA RICHARD
Chief Medical Officer
S - Sale
Common Stock
-4,757
$12.00
-57,084
1
$263.67M
2022-10-24
2022-10-25
CARTER LAURA
Chief Scientific Officer
S - Sale
Common Stock
-4,876
$12.00
-58,512
1
$263.67M
2022-07-15
2022-07-15
CARTER LAURA
Chief Scientific Officer
P - Purchase
Common Stock
6,934
$7.00
48,538
1
$263.67M
2022-07-15
2022-07-15
CHRISTIAN WAAGE
EVP, Tech Ops and Admin
P - Purchase
Common Stock
6,934
$7.00
48,538
1
$263.67M
2022-07-01
2022-07-05
CARTER LAURA
Chief Scientific Officer
S - Sale
Common Stock
-8,808
$8.00
-70,464
1
$263.67M
2022-06-22
2022-06-23
ARANDA RICHARD
Chief Medical Officer
S - Sale
Common Stock
-1,778
$7.00
-12,446
1
$263.67M
2022-05-04
2022-05-05
CARTER LAURA
Chief Scientific Officer
S - Sale
Common Stock
-1,262
$7.00
-8,834
1
$263.67M
2022-03-23
2022-03-24
CHRISTIAN WAAGE
EVP, Tech Ops and Admin
S - Sale
Common Stock
-10,722
$9.00
-96,498
1
$263.67M
2022-03-16
2022-03-17
ARANDA RICHARD
Chief Medical Officer
S - Sale
Common Stock
-6,278
$8.00
-50,224
1
$263.67M
2022-03-16
2022-03-17
CARTER LAURA
Chief Scientific Officer
S - Sale
Common Stock
-5,002
$8.00
-40,016
1
$263.67M
2022-03-16
2022-03-17
PETERSON CARYN
EVP, Regulatory Affairs
S - Sale
Common Stock
-6,279
$8.00
-50,232
1
$263.67M
2022-01-06
2022-01-10
CARTER LAURA
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
190K
$0.00
1
$263.67M
2022-01-06
2022-01-10
ARANDA RICHARD
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
190K
$0.00
1
$263.67M
2022-01-06
2022-01-10
CHRISTIAN WAAGE
EVP & General Counsel
A - Grant
Stock Option (Right to Buy)
190K
$0.00
1
$263.67M
2022-01-06
2022-01-10
HASNAIN FAHEEM
President & CEO
A - Grant
Stock Option (Right to Buy)
650K
$0.00
1
$263.67M
2022-01-06
2022-01-10
PETERSON CARYN
EVP, Regulatory Affairs
A - Grant
Stock Option (Right to Buy)
190K
$0.00
1
$263.67M
2021-10-25
2021-10-26
ARANDA RICHARD
Chief Medical Officer
S - Sale
Common Stock
-2,377
$12.00
-28,524
1
$263.67M
2021-10-25
2021-10-26
CARTER LAURA
Chief Scientific Officer
S - Sale
Common Stock
-2,377
$12.00
-28,524
1
$263.67M
2021-10-25
2021-10-26
PETERSON CARYN
EVP, Regulatory Affairs
S - Sale
Common Stock
-2,377
$12.00
-28,524
1
$263.67M
2021-06-30
2021-07-01
CARTER LAURA
Chief Scientific Officer
A - Grant
Common Stock
25,000
$0.00
1
$263.67M
2021-06-21
2021-06-22
ARANDA RICHARD
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
30,000
$0.00
1
$263.67M
2021-06-21
2021-06-22
ARANDA RICHARD
Chief Medical Officer
A - Grant
Common Stock
15,000
$0.00
1
$263.67M
2021-05-03
2021-05-05
CARTER LAURA
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
31,750
$0.00
1
$263.67M
2021-05-03
2021-05-05
CARTER LAURA
Chief Scientific Officer
A - Grant
Common Stock
10,820
$0.00
1
$263.67M
2021-04-16
2021-04-20
PETERSON CARYN
EVP, Regulatory Affairs
A - Grant
Stock Option (Right to Buy)
31,750
$0.00
1
$263.67M
2021-04-16
2021-04-20
PETERSON CARYN
EVP, Regulatory Affairs
A - Grant
Common Stock
10,820
$0.00
1
$263.67M
2021-03-23
2021-03-25
SALTER-CID LUISA
Chief Scientific Officer
S - Sale
Common Stock
-5,491
$9.00
-49,419
1
$263.67M
2021-03-23
2021-03-25
CHRISTIAN WAAGE
EVP & General Counsel
S - Sale
Common Stock
-5,490
$9.00
-49,410
1
$263.67M
2021-03-23
2021-03-25
GIRAUDO BRYAN
Chief Financial Officer
S - Sale
Common Stock
-5,490
$9.00
-49,410
1
$263.67M
2021-02-25
2021-03-01
GIRAUDO BRYAN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
90,000
$0.00
1
$263.67M
2021-02-25
2021-03-01
GIRAUDO BRYAN
Chief Financial Officer
A - Grant
Common Stock
45,000
$0.00
1
$263.67M
2021-02-25
2021-03-01
SALTER-CID LUISA
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
90,000
$0.00
1
$263.67M
2021-02-25
2021-03-01
SALTER-CID LUISA
Chief Scientific Officer
A - Grant
Common Stock
45,000
$0.00
1
$263.67M
2021-02-25
2021-03-01
HASNAIN FAHEEM
President & CEO
A - Grant
Stock Option (Right to Buy)
325K
$0.00
1
$263.67M
2021-02-25
2021-03-01
CHRISTIAN WAAGE
EVP & General Counsel
A - Grant
Stock Option (Right to Buy)
90,000
$0.00
1
$263.67M
2021-02-25
2021-03-01
CHRISTIAN WAAGE
EVP & General Counsel
A - Grant
Common Stock
45,000
$0.00
1
$263.67M
2020-10-14
2020-10-14
CHRISTIAN WAAGE
EVP & General Counsel
P - Purchase
Common Stock
2,500
$10.00
25,000
1
$263.67M
2020-10-14
2020-10-14
GIRAUDO BRYAN
Chief Financial Officer
P - Purchase
Common Stock
3,000
$10.00
30,000
1
$263.67M
2020-06-23
2020-06-23
GIRAUDO BRYAN
Chief Financial Officer
P - Purchase
Common Stock
2,000
$13.00
26,000
1
$263.67M
2020-02-14
2020-02-19
CHRISTIAN WAAGE
EVP & General Counsel
A - Grant
Stock Option (right to buy)
71,500
$0.00
1
$263.67M
2020-02-14
2020-02-19
CHRISTIAN WAAGE
EVP & General Counsel
A - Grant
Common Stock
46,500
$0.00
1
$263.67M
2020-02-14
2020-02-19
DUPONT JAKOB
Chief Medical Officer
A - Grant
Stock Option (right to buy)
71,500
$0.00
1
$263.67M
2020-02-14
2020-02-19
GIRAUDO BRYAN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
71,500
$0.00
1
$263.67M
2020-02-14
2020-02-19
GIRAUDO BRYAN
Chief Financial Officer
A - Grant
Common Stock
46,500
$0.00
1
$263.67M
2020-02-14
2020-02-19
GUJRATHI SHEILA
President & CEO
A - Grant
Stock Option (right to buy)
292K
$0.00
1
$263.67M
2020-02-14
2020-02-19
SALTER-CID LUISA
Chief Scientific Officer
A - Grant
Stock Option (right to buy)
71,500
$0.00
1
$263.67M
2020-02-14
2020-02-19
SALTER-CID LUISA
Chief Scientific Officer
A - Grant
Common Stock
46,500
$0.00
1
$263.67M
2019-12-31
2020-01-02
SALTER-CID LUISA
Chief Scientific Officer
G - Gift
Common Stock
-4,000
$0.00
1
$263.67M
2019-12-30
2019-12-31
DUPONT JAKOB
Chief Medical Officer
M - Exercise
Non-qualified stock option (Right to Buy)
-40,000
$0.00
1
$263.67M
2019-12-30
2019-12-31
DUPONT JAKOB
Chief Medical Officer
M - Exercise
Common Stock
40,000
$11.00
440K
1
$263.67M
2019-12-30
2019-12-31
DUPONT JAKOB
Chief Medical Officer
S - Sale
Common Stock
-40,000
$15.00
-600K
1
$263.67M
2019-12-27
2019-12-31
DUPONT JAKOB
Chief Medical Officer
S - Sale
Common Stock
-1,994
$16.00
-31,904
1
$263.67M
2019-12-27
2019-12-31
DUPONT JAKOB
Chief Medical Officer
M - Exercise
Non-qualified stock option (Right to Buy)
-1,994
$0.00
1
$263.67M
2019-12-27
2019-12-31
DUPONT JAKOB
Chief Medical Officer
M - Exercise
Common Stock
1,994
$11.00
21,934
1
$263.67M